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AN EXPLORATION OF NEUROANATOMICAL SIGNATURES OF PEDIATRIC
BIPOLAR DISORDER USING STRUCTURAL NEUROIMAGING

Jonika Tannous, BA
Advisory Professor: Jair C. Soares, M.D., Ph.D.

Bipolar Disorder (BD) is diagnosed using the Diagnostic and Statistical Manual (DSM)
criteria, which relies heavily on symptomatology. This method, however, lends itself to error due
to variance in symptom expression and is further complicated during childhood and adolescencea period marked by major anatomical and behavioral changes. Therefore, in order to institute early
and effective interventions, it is imperative that we develop more objective methods of mood
disorder characterization and diagnosis. Two proposed solutions for accomplishing this task
include 1) the generation of normative development models to assess BD risk and 2) data-driven
clustering of patients based on specific neuroanatomical profiles, i.e. biotypes. While the
normative development model was unable to quantify BD risk at an individual level, it
nevertheless emphasized the heterogeneous nature of both healthy and BD development. The
clustering analysis, however, was successful at parsing the variance in the BD sample which
resulted in the identification of two distinct BD biotypes. Whereas the BD clusters mapped onto
specific anatomical and neurocognitive patterns, symptom-based DSM subtypes were not
associated with any empirical measures of mental health. Hence, these findings are testament to
the potential of unsupervised and unbiased computational methods in the future of BD
diagnostics.
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Chapter 1: Introduction

1

Bipolar disorder (BD) is a mental illness characterized by periods of mood irregularity
that may shift between mania, hypomania, depression, and euthymia (Grande et al. 2016).
About 2.4% of people worldwide have been diagnosed with BD, and the U.S. in particular has a
high lifetime prevalence at 4.4% (Kessler et al., 2005; Merikangas et al., 2011). BD is one of
the leading causes of disability and is associated with extensive neuroanatomical and cognitive
deficits (Alonso et al. 2011). BD subjects are often reported to have smaller brain regions in
systems that are responsible for executive functioning and attention, and memory consolidation,
as well as emotion and fear response. White matter (WM) pathways responsible for connecting
and relaying signals between these systems have also been shown to have decreased integrity
largely due to demyelination (F. Lin et al. 2011; Bellani et al. 2009; Heng, Song, and Sim 2010).
These anatomical abnormalities are then heavily linked to corresponding neurocognitive deficits
that impact psychosocial behavior, mood regulation, and impulsivity (Lima, Peckham, and
Johnson 2018).
For many BD patients, the first episode emerges during childhood and adolescence (P.-I.
Lin et al. 2006). Pediatric BD is characterized by many of the same deficits seen in adult
populations (Leibenluft, Charney, and Pine 2003). Moreover, earlier onset of BD often predicts
worse outcomes, which include increased rates of drug and alcohol abuse, comorbidity, and
suicidality (Leverich et al. 2007). The poor prognosis of pediatric BD is often due to delays in
diagnosis and treatment, thus emphasizing the need for early detection (Post et al. 2010).
Identification of BD, as well as other mood disorders, remains difficult since symptom
expression often does not reflect the underlying causes of illness and tends to vary from patient
to patient (M. Song et al. 2017). This is further complicated during childhood and adolescence, a
critical period in mental health development marked by major anatomical and behavioral changes
(Schulenberg, Sameroff, and Cicchetti 2004). Thus, years of persistent reliance on
2

symptomatology in the clinic, as is standard in the Diagnostic and Statistical Manual (DSM), and
research based on false assumptions of population homogeneity has led to symptom-based
diagnostic labels that do not align with neurobiology and a lack of standard BD biomarkers that
can be used in practice (Marquand, Wolfers, et al. 2016; Wolfers et al. 2018). Therefore, in order
to institute early and effective interventions, it is imperative that we develop more objective
methods of mood disorder characterization and diagnosis. Two proposed solutions for
accomplishing this task include 1) the generation of normative development models and 2) datadriven clustering of patients, i.e. biotypes.
Mood disorders are typically regarded as neurodevelopmental in nature; hence, charting
brain changes across development could provide a normative model that would assist in early
identification of at-risk patients (Vértes and Bullmore 2015). While many studies have used
imaging techniques to track brain changes in gray matter (GM) volumes, GM morphology, and
functional connectivity (Wang et al. 2012; Cao et al. 2015; Khundrakpam et al. 2015; Lenroot
and Giedd 2006; Yeo et al. 2011), little research has been done to develop an imaging model that
can be used to screen for irregularities (Marquand, Rezek, et al. 2016). Ideally, clinicians should
have access to a tool that uses neuroanatomical measures to assess mental health risk-- a similar
role to the body mass index or the blood pressure chart. Specifically, when charting development,
normative models can be used to predict a subject's age. Provided the subject is predicted to be
substantially younger than their true age, this discrepancy may imply delayed neurodevelopment,
which is a signature of pediatric BD (Roybal et al. 2012). GM volumes could provide the basis of
such a model, as GM trajectories are reliably consistent within the literature and have already
been shown to be able to predict the ages of healthy subjects (Cao et al. 2015).
Beyond assessing mental illness risk, it is crucial to be able to classify and ultimately treat
subjects based not only on their symptoms but also their neurophysiological profile. Recently,
3

advances in computational modeling have allowed for holistic processing of clinical and
neuroimaging data, which has prompted the discovery of biotypes that do not adhere to symptombased DSM labels (Bak et al. 2017). A groundbreaking study by Clementz et al. examined adult
BD, schizoaffective, and schizophrenic patients and used both neurocognitive testing and
measures of perceptual processing to develop three distinct biotypes (Clementz et al. 2016). All
three biotypes contained patients from each of the illness groups. Further examination showed
that each biotype had unique cognitive deficits and differed in social functioning, rates of
psychosis, and location of gray matter volume reductions. A patient’s DSM label, on the other
hand, was not associated with a unique clinical phenotype and was only implicated in symptom
severity. This study along with others, which have examined disorders such as adult depression
and adolescent ADHD, highlight both the inconsistencies of DSM labels and the need for
homogeneous, verifiable biotypes (Drysdale et al. 2017; Fair et al. 2012). Indeed, the DSM
specifies three BD subtypes, BD-1, BD-2, and BD-NOS, yet biological distinctions between them
have yet to be substantiated and it is unclear whether these subtypes align with data-driven
biotypes (Martin Tesli et al. 2015; M. Tesli et al. 2014).
This dissertation aims to address the lack of neurodevelopmental decision support tools in
pediatric BD and explore how BD biotypes can make sense of diagnostic heterogeneity. This will
be accomplished in three main parts:
Part 1 describes the subject sample and introduces the imaging methodologies that
are the foundation of all analyses presented in later chapters. In addition, using traditional
assumptions of homogeneity, differences between BDs and HCs are examined with both
classical parametric methods and machine learning in order to characterize BD and
ascertain whether our sample exhibits expected patterns reported in previous studies.
Concordance with the BD literature is thus a testament to the validity of the sampling and
4

lends credence to the potential reproducibility of the novel analyses conducted in the
subsequent chapters. Furthermore, this section allows for the later contrasting of results
obtained through assumptions of homogeneity and those resulting from non-diagnostically
biased computational methods.
Part 2 aims to generate a normative development model based on the GM volume
trajectories of healthy children and adolescents which is then fit to the BD sample. Age
estimation errors are interpreted as a sign of altered neurodevelopment. It is hypothesized
that BD subjects will exhibit neurodevelopmental delays, and thus the predicted ages of
BD subjects will be younger than their true ages. It follows that the larger the difference
between a subject’s true age and predicted age, the more developmentally delayed a
subject is and the higher their neurodevelopmental risk for BD would be.
Part 3 aims to use non-diagnostically biased and unsupervised computational
clustering methods to investigate BD heterogeneity. BD subjects are clustered based on
GM volume patterns across the cortex and subcortex, which creates groups with distinct
GM biotypes. The symptomology, neurocognition, GM integrity, and cortical morphology
of each BD cluster is examined. It is hypothesized that GM volume biotypes will not be
reflective of DSM subtype labels. Rather, data-driven biotypes will map onto other
neurocognitive and morphological abnormalities while DSM subtypes will not.
Ultimately, this dissertation will further strengthen the case for BD diagnostics to extend
beyond traditional symptom-centered methods and delve into neurobiological solutions that will
progress the field closer to the realm of precision medicine.

5
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Chapter 2: Processing and Quality Control of MRI and DTI Images
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Introduction
Structural imaging, specifically T1-Weighted MRI and DTI, allows for in vivo
characterization of neuroanatomy and can be used to track brain development across childhood
and adolescence (Barnea-Goraly et al. 2005; Courchesne et al. 2000).
T1-Weighted sequences produce brain images by using pulse sequences that detect
differences in relaxation time to visualize the contrasts between GM and WM tissues as well as
CSF (Chen et al. 2015). Images can then be used to assess brain morphometry, including GM
volumes, cortical thickness, and gyrification. During childhood, subcortical volume has been
shown to increase while cortical volume and thickness decreases due to cortical thinning
(Wierenga et al. 2014; Sowell et al. 2002). Gyrification has also been shown to decrease
throughout development (Cao et al. 2017).
DTI imaging techniques allow for the visualization of WM fibers by quantifying the
diffusive properties of water within tissue. The metrics typically used to describe diffusivity are
axial, radial, and mean diffusivity (AD, RD, and MD, respectively), as well as fractional
anisotropy (FA) values. AD measures diffusivity running along an axon while RD measures the
diffusion perpendicular to an axon (Cascio, Gerig, and Piven 2007). Thus, high AD values can
be interpreted as a sign of axonal integrity, while low AD values have been implicated in axonal
degeneration (S.-K. Song et al. 2003). Conversely, high RD values suggest possible
demyelination (S.-K. Song et al. 2002). MD is a weighted average of AD and RD and provides
an inverse indicator of membrane density. FA is the weighted ratio of AD to RD, is sensitive to
microstructural changes in WM, and thus serves as a summary metric of WM integrity, with
higher FA values associated with healthy WM. During childhood and adolescence, FA is
expected to increase with age, while MD and RD decrease (Brouwer et al. 2012). While some
studies report increased AD during development, AD has also been found to decrease in certain
8

WM tracts, but at a slower rate than RD, thus resulting in increased FA (Qiu et al. 2008;
Krogsrud et al. 2016).
When investigating the WM and GM signatures in BD, many studies use a case control
design, in which BD subjects are compared to HCs. These analyses, however, are credible only
if the quality of the data is assured. Thus, in order to ensure validity of results and future
reproducibility, it is imperative to perform visual quality control (QC) at multiple stages
throughout the image processing pipeline. Furthermore, replicating known age and gender
trends within the HC data sample provides confirmation that the comparison group is indeed
within the healthy norm. Otherwise, any results found will not aptly capture real-world
differences between BDs and HCs, and hence will not have potential to be translated into the
clinic.
The following chapter will describe the pediatric dataset that was analyzed throughout
this dissertation and will detail the MRI and DTI methodologies that were used to quantify GM
and WM features. In addition, this chapter will document the QC measures that were
implemented.

Methods

Subjects
The sample was acquired through the Houston Pediatric Bipolar Consortium, which is a
collaboration between McGovern Medical School (PI- Jair C. Soares, M.D., Ph.D.) and the
Baylor College of Medicine (PI- Kirti Saxena, M.D. Both sites followed the same data
acquisition protocols. Subjects were recruited through flyers, radio, and newspaper
advertisements from the local community and psychiatric clinics. To meet the inclusion criteria
for the clinical sample, subjects needed to be between six and eighteen years of age and have a
9

diagnosis for BD-I, BD-II, or BD-NOS according to DSM-IV. All subjects and their parent or
legal guardian gave written informed consent and/or assent. This study was approved by the
local IRB. Exclusion criteria included head trauma with residual effects, neurological disorders,
and uncontrolled major medical conditions. Healthy controls were excluded if they had a history
of any Axis I disorders, had a first-degree relative with any Axis I disorder, or used
psychoactive medication less than two-weeks before the study. Subjects were evaluated through
a socio-demographic history form for age, gender, and years of education. Axis-I diagnoses and
clinical characteristics were assessed with the Structured Clinical Interview for DSM-IV (SCID)
administered by fully trained research assistants or postdoctoral fellows who were supervised by
an experienced research psychiatrist.
The final sample included 43 BD (Male: 17, Female: 26) subjects and 57 HC (Male: 28,
Female: 29). There were no differences in age (BD: M=13.1 ± 3.5 years; HC: M=13.1 ± 2.9
years, t(81)= 0.09, p=0 0.93) or gender (X2(1)= 0.56, p=0.45) between the two groups.

Imaging
McGovern Medical School’s Philips
Ingenia Medical Systems Scanner was used to
acquire T1-weighted and diffusion weighted
structural brain images for each subject.
Imaging parameters can be found in Table 1.
All subject scans were forwarded to a licensed
radiologist in order exclude any subjects with
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gross anatomical abnormalities and neurological conditions.

Table 1. Imaging Parameters.

Grey Matter Processing
After a thorough visual inspection of all the brain images for visual artifacts, MRI scan
preprocessing and segmentation was performed using FreeSurfer suite version 6.0 (Dale et al.,
1999; Fischl et al., 2002; Jovicich et al., 2006). FreeSurfer is a fully automated software that
performs motion correction, intensity normalization, automated topology correction, and atlas
based cortical + subcortical segmentation and labeling of MRI images (Bruce Fischl et al.
2004). FreeSurfer is one of the most popular methods of automated segmentation and has been
shown to yield comparable results to manual tracing (Grimm et al. 2015; Perlaki et al. 2017).
Segmentation results in 101 brain areas, 68 cortical and 33 subcortical. Visual QC was
performed on all FreeSurfer segmentation outputs and all subjects were deemed to have been
segmented satisfactorily. Example segmentations are shown in Figure 2.
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White Matter Processing
Using FSL’s FMRIB Diffusion Toolbox (fsl.fmrib.ox.ac.uk/), FA, MD, RD, and AD
maps for each subject were generated after correcting for eddy current distortions, creating a
brain mask by removing all non-brain tissue using the brain extraction tool (BET), and fitting a
diffusion tensor model to raw diffusion data (DTIFIT). As a visual QC, subjects’ FA maps were
examined for artifacts and abnormalities. Seven subjects were excluded from analysis. In order
to assure that the principal vectors aligned well with neuroanatomy, the remaining subjects had
their FA maps overlaid with principal eigenvector, or “V1”, maps. An example overlay is shown
in Figure 3.

12

TRACULA (TRActs Constrained by UnderLying Anatomy), an automated tractography
software, was used to generate 18 major WM pathways. Specifically, diffusion maps fitted by
FSL are used along with a subject’s FreeSurfer segmentations and a WM atlas to conduct
probabilistic tractography. An example TRACULA output is shown in Figure 4.

Statistics
After visual QC, the relationships between age, gender, and grey matter (GM) volumes
were examined in healthy subjects to establish the validity of patterns observed in the data.
General linear models examined the relationships between age and total cortical volume,
subcortical volume, and FA, AD, RD, and MD for the 18 TRACULA tracts in HCs. All GLMs
accounted for interactions between age and gender. General linear models were also used to
look for gender differences in GM and WM. All volumetric analyses controlled for Total
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Estimated Intracranial Volume (ICV). GLM analyses were conducted in R-Studio version
1.21335 and significance was set at p<0.05.

Results

Grey Matter
Controlling for ICV, cortical volume was found to decrease with age (p=0.02) and
subcortical volume was found to increase with age (p=0.003) (Figure 5). There were no
significant interactions between age and gender. Females were found to have smaller total
subcortical and cortical brain volumes than males (p=8.52 X 10-10, p= 9.8 X 10-7).
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White Matter
No significant age effects were found in the TRACULA generated pathways when
accounting for interactions between age and gender, despite only one measure having a
significant interaction (FA of right inferior longitudinal fasciculus: pinteraction=0.05). This was
likely due to two interaction terms decreasing the power of the analysis. When the GLM was
changed to control for gender and only tested for age X group interactions, eleven measures had
significant relationships with age (Figure 6). With regards to gender differences, only the FA
and AD values in the cerebrospinal tract were significant, with females having lower values for
both measures (p=0.008; p=0.01).
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Discussion
In this sample of 100 subjects, visual QC retained all GM data, while 7 subjects were
excluded from DTI analysis. HCs exhibited trends in accordance with the literature, specifically
increases in ICV and subcortical GM volumes and decreases in cortical GM volume (Sgouros et
al. 1999; Sowell et al. 2002). Expected gender effects stemming from males typically having
larger brains were also observed (Groeschel et al. 2010). WM showed increases in FA, which
corresponded with greater WM integrity, as HC subjects develop, which is also in accordance
with the literature (Lebel and Beaulieu 2011).
The confirmed age trends as well as the imaging methods and QC measures described in
this chapter lay the foundation for the subsequent analyses within this dissertation. Ultimately,
results are only as valid as the data that is used to generate them. Hence, assuring the quality of
data and testing for reproducible patterns lends credence to the more computationally complex
analyses to come.

16

Chapter 3: Neuroanatomical and Cognitive Differences
Between HCs and BDs

17

Introduction
BD in both youth and adulthood is associated with GM, WM, and cognitive
abnormalities which have been shown to be linked to increased illness severity and poorer
psychosocial functioning (Goswami et al. 2006; Heng, Song, and Sim 2010; Bearden, Woogen,
and Glahn 2010). BD patients are often found to have smaller volumes in many brain regions
throughout the cortex and subcortex. Some of these regions include structures within the limbic
system, such as the hippocampus, amygdala, thalamus, and hypothalamus, which are integral to
memory, sensory, cognitive, and emotional processing (Catani, Dell’acqua, and Thiebaut de
Schotten 2013). Areas within the frontal cortex which are responsible for executive functioning
and inhibition control have also been reported to be smaller in subjects with BD (Arnone et al.
2009) .
Beyond volumetric deficits, studies have suggested impaired WM connectivity in frontolimbic areas due to decreased FA (Barnea-Goraly et al. 2009). The corpus callosum, which is
the main pathway for inter-hemispheric signaling, is frequently cited as being smaller and less
myelinated in BD (Brambilla et al. 2003; Caetano et al. 2008; Atmaca, Ozdemir, and Yildirim
2007). This impairment in inter-hemispheric networks is reflected in decreased efficiency and
abnormal network organization in BDs (Leow et al. 2013).
Based on the literature, it appears that BD subjects suffer from widespread
neuroanatomical abnormalities that are linked to impaired performance in numerous cognitive
domains (Haldane et al. 2008; Poletti et al. 2015). Thus, to capture the full extent of
neuroanatomical and cognitive abnormality in pediatric BD, the following chapter will explore
GM from areas across the whole brain, WM in 18 major pathways, and cognitive differences in
a diverse battery of tasks. It is hypothesized that fronto-limbic volumes will be smaller, WM
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pathways connecting the frontolimbic system will have less structural integrity, and that
cognitive performance will in turn be worse in BD youth.

Methods
GLMs examined group differences between HCs and BDs in GM, WM, and Cognition.
GM and WM data were acquired using the FreeSurfer and TRACULA methodologies described
in Chapter 1. Cognitive data was
acquired using the Cambridge
Neuropsychological Test Automated
Battery (CANTAB). The list of
tasks administered and the cognitive
domains they measure are listed in
Table 2. All analyses controlled for
age and gender. GM analyses also controlled for ICV. Results were FDR-corrected for multiple
comparisons. All analyses were conducted in RStudio version 1.2.1335 and significance was set
at p<0.05.

Results

Grey Matter
Volumes in 73 out of the 101 brain areas were significantly different in BD subjects than
HCs. 71 of these regions survived FDR correction. Due to a large number of significant areas,
the Bonferroni method of correction was implemented as it is more conservative than FDR
(Narum 2006). After Bonferroni correction, 26 areas remained significant: 9 subcortical and 17
cortical. BDs had smaller volumes in all significant subcortical areas, which included the
19

bilateral cerebellum and hippocampus, the right ventral pallidum and ventral diencephalon, and
left thalamus and caudate (Figure 7). The 17 significant cortical areas, which are visualized
along with their Bonferroni corrected significance in Figure 8, were also smaller in BDs.
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White Matter
There were no WM differences between HCs and BDs.

Cognition
There were differences in BD and HC cognitive performance in the AGN, CGT, SOC,
SSP, IED, and RVP tests (Figure 9). There were eleven significant measures and in all except
for the CGT quality of decision making, BDs performed worse than HCs. Four of the eleven
significant measures survived FDR correction: AGN total omissions shift negative, CGT
deliberation time, RVP accuracy, and RVP mean latency.
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Discussion
Diffuse volumetric deficits were found across the subcortex and much of the cortex of
BD subjects. Although there were no differences in WM integrity, compared to HCs, BD
subjects showed deficits in affective processing, spatial reasoning and working memory,
executive functioning and planning, and attention. These results are largely in accordance with
the literature, and provide evidence for pervasive GM abnormalities and cognitive deficits in
BD (Sarnicola et al. 2009).
The widespread nature of the reported BD volumetric abnormalities alludes to systemwide impairments. Thus, the lack of significant WM differences is unexpected as WM is
responsible for connecting said systems. Although WM abnormalities are frequently cited in the
BD literature, the absence of WM differences in BD has also been reported (López-Larson et
al. 2002). It is possible that GM signatures are more robust and thus are better detected at earlier
stages of BD. More studies examining both GM and WM differences in BDs and HCs are
necessary to determine which is the more consistent indicator of BD pathology.
The overwhelming presentation of GM abnormalities within the BD group provides
support for the possible utility of using GM metrics to build future risk assessment and decision
support tools, which will be explored in later chapters.
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Chapter 4: SVM Classification of BDs and HCs
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Introduction
While group-wise analyses, such as those conducted in the previous chapter, give crucial
insights regarding BD neuroanatomy, these group differences cannot be used to inform
diagnostic decisions at the individual level (Mwangi, Tian, and Soares 2014). In addition, the
widespread nature of GM abnormalities in BD reported demonstrates the necessity for models
that can synthesize data from across the whole-brain (Orrù et al. 2012). Such analyses may
uncover underlying links between GM areas and identify how these systems may then
contribute to the neurological underpinnings of BD.
Machine learning methodologies have gained popularity within psychiatric
neuroimaging due to computational capabilities that allow for the synthesizing of information
from across the whole brain. Models can then use these patterns to predict diagnosis, treatment
response, and other clinically valuable outcomes (Bzdok and Meyer-Lindenberg 2018;
Chekroud et al. 2016; Mwangi et al. 2015). While none of these studies have yet to be
successfully translated into the clinic, they serve to highlight the main predictors of mental
illnesses and lay the foundation for future targeted interventions and larger scale predictive
models (Gillan and Whelan 2017).
The following chapter will use GM volumes from across the cortex and subcortex to
predict BD vs HC diagnosis using a principal component analysis (PCA) + support vector
machine (SVM) method in children and adolescents. Based on the volumetric differences
reported in the literature and in Chapter 2, it is hypothesized that GM volumes will be able to
reliably separate BDs from HCs and highlight neuroanatomical signatures of pediatric BD.
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Methods
The classification model was generated using ICV-corrected and scaled data in order to
mitigate the effects of brain size and ensure that large brain regions do not have an outsized
influence on the classification model. The 101 corrected and scaled brain regions were then fit
by a Principal Component Analysis (PCA) in order to reduce the dimensionality of the dataset.
PCAs collapse correlated data into orthogonal vectors, i.e. components, that preserve much of
the variation in a dataset (Monfreda 2012). As many brain region volumes, especially those
within the same systems, are correlated, with larger volumes in one area often being linked to
larger volumes in others, GM volumetric data can be reduced to a much smaller dataset, thus
increasing the power of the analysis and decreasing the risk for overfitting. The resulting
principal components were then fit by a 2-class linear SVM intended to classify subjects as HCs
or BDs. Briefly, SVMs use training data to fit a
hyperplane that will most optimally separate subject
groups in a multi-dimensional data space (Vapnik 2000;
Mwangi et al. 2015).
Before running a PCA, the number of PCA
components (n) must be pre-selected. This decision was
made based on which n would produce the most accurate
classifications. The knee/elbow method was used to
select that max n that would be tested for model
optimization to avoid including too many components
into the final model, which could possibly render it
uninterpretable (Figure 10) (Satopaa et al. 2011). The
Scikit-learn GridSearch function with leave-one-out cross-validation, was used to select the
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optimal n of components in the PCA. The GridSearch tested all n components from one to the
max n. The PCA result was then Z-scored using Scikit-learn’s Standard Scaler before being fit
by a linear SVM with the following parameters: class weight was set to the proportion of BDs
and HCs in the sample (BD: 43, HC: 57), maximum iterations to 1X106, tolerance to 1X10-6,
and the rest of the parameters remained at the Scikit-learn model defaults. The n that yielded the
highest average SVM prediction accuracy,

# 𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑙𝑦 𝑐𝑙𝑎𝑠𝑠𝑖𝑓𝑖𝑒𝑑 𝑠𝑢𝑏𝑗𝑒𝑐𝑡𝑠
𝑡𝑜𝑡𝑎𝑙 # 𝑠𝑢𝑏𝑗𝑒𝑐𝑡𝑠

, across all test sets, was

then selected as the final n. In order to interpret the meaning of the components included in the
final SVM model, for each component, the top loadings from individual brain areas were
examined.

Results

Role of PCA Components in SVM Model
The knee method indicated the
max n to be 29 PCAs (Figure 10) and
the Gridsearch indicated that seven
principal components, which capture
68.0% of the variance within the data,
yielded the best SVM accuracy (Figure
11). The coefficients of the principal
components making up the SVM are
shown in Figure 12. Principal
components with negative coefficients
are characteristic of HCs, while positive
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are characteristic of BDs. Using the loadings of brain areas (Figure 13), the anatomical meaning
of each component was summarized as is listed in Table 3.
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Model Performance
The final model had 63% accuracy. Figure 15 details the model’s performance for HC’s
and BD’s and indicates that the model performed better for HCs than BDs (84% VS 35%
prediction accuracy). The model performed equally well for both genders, and the age
distributions of correct and incorrect responses were not significantly different.
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Discussion
The HC vs BD
classification model had
63% accuracy.
Interestingly, the model
classified 83% of HCs
correctly while accuracy for
BDs was much lower at
35%. Furthermore, despite
accounting for an unequal
number of BDs and HCs in the training set, the model still classified 76% of subjects as HC
versus the sample rate of 57%. Examining the predictors of the SVM model indicated predictive
patterns contrary to the BD literature as well the results reported in Chapter 2 using classical
statistical methods. ICV scaling and heterogeneity of BD are possible reasons for the
discrepancies between the patterns identified by the SVM model and the BD literature as well as
the poor BD classification.
Accounting for the effects of ICV in neuroimaging has become standard. This is done in
order to minimize the confounding effects of cranium size on GM patterns observed
(Voevodskaya et al. 2014). In classical statistical methods such as GLMS, this is often done by
including ICV as a covariate (Sanfilipo et al. 2004). When conducting a PCA, however, data
must be scaled, i.e. divided by ICV, as there is no method to account for covariates otherwise.
These differing methods of ICV adjustment may have vast consequences on results. Indeed, the
classical statistical analysis in Chapter 2 was repeated with ICV scaled data instead of the
original ICV controlled analysis and all previously significant regions became null. Other
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studies have also reported on the pronounced effects ICV scaling has on results (Pintzka et al.
2015; Voevodskaya et al. 2014). It is possible that scaling for ICV makes analyses less sensitive
to group differences as BDs in our sample have significantly smaller ICVs than HCs (p=0.003)
and ICV is highly correlated to GM volume. Chapter 5 will expound upon the role ICV has to
play in the GM signatures of BD.
Heterogeneity of mental disorders such as BD complicate comparisons and
classifications between BDs and HCs due to the fact that many analyses, including the present
SVM, regard BD as being one uniform group (Van Rheenen et al. 2017; Dacquino, De Rossi,
and Spalletta 2015). Research on mental disorders as well as discoveries in other fields, such as
oncology and cardiology, have highlighted the fact that having the same diagnosis and selfreported symptoms does not guarantee homogeneousness when it comes to the mechanism,
pathophysiology, or treatment of any given illness (Senni et al. 2014; von Minckwitz et al.
2011; Ivleva et al. 2017). Thus, Chapter 6 will explore the heterogeneity of the BD sample, how
it may have affected SVM performance, and how accounting for it provides a clearer picture of
neuroanatomical abnormalities of the BD sample.
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Chapter 5: Normative Age Prediction Model
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Introduction
BD is often regarded as a neurodevelopmental disorder and early onset BD has been
associated with poorer prognosis and increased disease severity due to delays in treatment
(Leverich et al. 2007). It has been postulated that characterizing healthy GM development and
tracking how BD youth deviate from the typical trajectory will aid scientists in early
identification and treatment of pediatric BD (Vértes and Bullmore 2015). It is important,
however, that these normative models can account for the fact that the whole brain is part of the
neurodevelopmental process and different regions have differing volumetric trends over time
(Paus 2005). In addition, using computational resources to integrate signals from across the
cortex and subcortex is likely to provide a larger effect size than relying on specific regions
alone (Reddan, Lindquist, and Wager 2017).
One way to estimate normative development is through age prediction models.
Specifically, pediatric subjects predicted to be younger than their age are considered to be
developmentally delayed while those predicted to be older are developmentally accelerated.
Building on GM as a marker of BD abnormality, GM volumes from cortical and
subcortical areas of HCs will be used to build a normative development model that would be
used to assess the BD subjects. Due to BDs often having smaller GM volumes than their HC
cohorts, along with other deficits in cognition and emotional regulation, it is hypothesized that
when fitted by the normative model, BDs would be predicted to be younger than their true ages
(Robinson et al. 2006; Dickstein and Leibenluft 2006). This would then provide further
evidence of neurodevelopmental delay in pediatric BD and thus serve as a possible quantifier of
BD risk.
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Methods
The age prediction model was based on normative development, so HCs were used to fit
a model which was then tested on BD subjects. The residuals, i.e. the error that results from the
difference between the predicted age and the actual age, were used as a metric of normative
development, with subjects with small residuals having typical development and large residuals
having atypical development.
ICV scaled and standardized volumetric data from the FreeSurfer segmentations were
fed into a PCA to reduce dimensionality before being fit into a ridge regression in order to
predict age. Ridge regressions are penalized linear regressions that are able to scale the weight
of predictors using L2 penalties, which are calculated by taking the square root of all model
coefficients and multiplying them by every coefficient (McDonald 2009). Ridge regression
models are ideal for collinear datasets and their penalization adjusts coefficients to levels that
are more likely to be representative of the whole population, and thus have greater potential for
translation (Pagel and Lunneborg 1985).
The PCA n was selected based on the n which would produce the most accurate ridge
regression predictions. The max n components, as indicated by the knee/elbow method, was 20
(Figure 16). Due to sample size limitations, the n could not be optimized using Sci-kit learn’s
Gridsearch cross-validation function. Withholding a portion of the sample and training with the
rest resulted in underfit models with significantly lower R-squares than when the complete
dataset was used (Figure 17 A). Thus, the GridSearch could not provide useful insight regarding
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the optimal n of components. Instead, a pipeline was created which performed the following for
each n from 1 to the max n (Figure 17 B):
1. GM data of HCs was ICV scaled and then Z-scored
using the Sci-kit Learn StandardScaler.
2. A PCA with n components was fit to the
standardized data.
3. PCA output was scaled before being fit into Sci-kit
Learn’s Ridge Regression model with leave-one-out
cross-validation. In this step, the model is fit using
all but one of the subjects. The model then predicts the age of the left-out subject. This is
done until HC ages have been predicted.
4. The R2 is calculated using the predicted and actual HC ages.
The n of components that resulted in the highest R2 was chosen as the optimal n.

Although this iterative algorithm does provide an empirical method for n component
selection, it does not contain cross-validation at the n component step and only at the ridge
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regression step. Therefore, one should be aware that this n of PCAs chosen may not be
transferable to a new dataset.
In order to interpret the meaning of the components included in the final ridge regression
model, for each component, the top loadings from individual brain areas were examined. To
predict BD ages the final pipeline and resulting model was applied to BDs. Model performance
was evaluated using residuals and the effects of age, gender, and subject group on residuals
were studied using linear models and t-tests. Model generation was conducted in Python 3.7 and
model performance analyses were conducted in RStudio and significance was set at p<0.05.

Results

Principal Components of Ridge Regression
The knee/elbow method indicated that the max n component to be 20 (Figure 16). The
first eleven components in the PCA analysis captured 74% of the variance in the data and
provided the highest R2 of the ridge regression model (0.49) with a mean absolute error (MAE)
of 1.63 years (Figure 18). Table 4 shows a summary of the main loadings and ridge regression
coefficients of each principal component. The table also indicates whether high component
values were characteristic of younger or older subjects.
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Model Performance

When predicting the ages of all subjects, the final model had an R2 of 0.44 and a mean
absolute error of 1.87 years. Broken down by group, the model had R2 values of 0.49 and 0.39,
and MEs of 1.63 and 2.19 for HCs and BDs, respectively (Figure 20 A). Residuals of age
predictions were not statistically different between genders for both HCs and BDs (Figure 20
B). Linear models examining the relationship between residuals and age found residuals to
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decrease with age (HC: R2=0.33, p=2.91 X 10-6; BD:
R2=0.71, p=1.72 X 10-12), meaning the model was worse
at predicting subjects on the extremes of the age
distribution than for subjects in the middle of the age
distribution (Figure 20 C). The residuals of HCs and
BDs were not significantly different (Figure 21).

Discussion

The normative age prediction model identified
several systems and brain regions that have been heavily implicated in neurodevelopment. The
overall model had a respectable R2 of 0.44 and was better fit to HCs than BDs (R2 of 0.49 vs
0.39, mean absolute error of 1.63 vs 2.19 years), implying that there is more variation and
heterogeneity within the BD dataset that is unaccounted for. However, on an individual level,
the model could not be used to identify BD subjects at risk as there were no significant
differences in residuals between HC and BDs. Therefore, it would not be possible to look at a
specific subject’s residual and be able to assess neurodevelopmental abnormality and BD risk.
The main component that predicted age was component 2, which was a measure of a
large brainstem, cerebellum, and ventral diencephalon. These regions have direct pathways
between them and play integral roles in autonomic brain functions, as well as motor control and
balance (Dietrichs 1984). Thus, the PCA was able to group together a functional brain system
based on the collinearity of their brain volumes across HCs. Other studies have emphasized the
role of these three regions throughout development (Acton 2011; Stoodley 2016; Xie et al.
2012). Notably, a study from our group used another independent sample from NIH that
contained 303 children and adolescents between the ages of 4 and 18 to develop a brain
maturation index. Their resulting model placed these three brain regions within their top
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predictors of maturation with the brainstem being first (Cao et al. 2015). The main CSF system
component, which contained the individual parcellations of the ventricles, choroid plexus, and
CSF estimates also was larger in older subjects, a pattern that is characteristic of healthy neural
development (Sowell et al. 2002). The PCA also grouped together various frontal, parietal, and
temporal cortical areas that tended to decrease with age. This cortical thinning has been widely
reported in the developmental literature and has been associated with improvements in cognitive
performance and intelligence (Squeglia et al. 2013; Vijayakumar et al. 2014; Shaw et al. 2006).
There were some cortical areas, however, that were shown to increase in age, specifically the
entorhinal, pars opercularis, cuneus, precalcarine, and lingual cortices. Although little has been
published on the developmental trajectories of these areas, a study has shown entorhinal
thickness to increase during childhood and adolescence (Hasan et al. 2016). As cortical
thickness and volume have been shown to have strong positive correlations with one another, it
is also expected that volume would follow a similar trajectory (Storsve et al. 2014). These
results give validity to the normative model as the main predictors are regions commonly cited
in the neurodevelopmental literature.
When the normative model was applied to BDs, the predictions had a decrease in R2 and
an increase in mean absolute error compared to HCs. This suggests a greater degree of
heterogeneity within the BD sample and more deviation from the healthy trajectory as a whole.
However, once the distributions of the model’s residuals were compared, they were not
significantly different between HCs and BDs. This fact renders the current normative model
ineffective as a way to assess neurodevelopmental deviation. While a larger sample size, such as
the 303 subjects in the brain maturation index study (BMI) (Cao et al. 2015), may result in a
higher R2 (0.67 VS. 0.49), when performance is evaluated based on the mean absolute error,
there was not much difference between the BMI study and the present one (1.69 years vs 1.63
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years). Thus, a larger healthy training sample does not in and of itself guarantee a more precise
prediction. One must take into consideration, however, that the data used was cross-sectional,
and having longitudinal data may result in a more valid predictive model that can better account
for intrasubject variability. However, this would still not solve the issue of intersubject
variability, as large longitudinal studies still report large variation within healthy samples
(Lenroot et al. 2007).
Creating a normative development model to assess BD risk has been postulated as a
potential decision support tool for clinicians. However, impediments in model development may
stem from the large variation within HCs themselves; there is no distinct boundary that
separates BD volumes from HCs, rather the distribution of volumes across groups is largely
normal. It is expected that other mental disorders may encounter similar overlaps in
developmental distributions (Giedd et al. 2015). Nevertheless, the normative development
model’s inability to assess risk at the individual level does not discount the value of a nonsupervised computational approach validating the role of many of the areas and systems which
have been identified as integral to human neurodevelopment.
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Chapter 6: Clustering of BD
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Introduction
Illness heterogeneity is a hallmark of BD and other mental disorders. Indeed, the DSM
manual indicates that there are three BD subtypes: BD, BD-I, BD-II, and BD-NOS. In brief,
BD-I is marked by the occurrence of at least one manic episode, BD-II by one hypomanic and
one depressive episode, and BD-NOS by alternating depressive and manic symptoms that do not
meet the criteria for a BD-I or BD-II diagnosis (Glass 2009). Regarding the stability of BD
subtypes, a study has shown 7.2% of BD-I subjects converting to BD-II and 7.5% of BD-II
subjects converting to BD-I (Coryell et al. 1995). A longitudinal study of 263 BD children and
adolescents, however, showed 20% of BD-II subjects converting to BD-1 and 25% of BD-NOS
subjects converting to BD I, thus implying less stability in pediatric BD subtypes (Birmaher et
al. 2006). Furthermore, studies looking to identify biological differences between BD subtypes
report conflicting results with little consensus in the literature (Martin Tesli et al. 2015; M. Tesli
et al. 2014).
It is important to note that the DSM subtypes are defined using symptomology and not
by any mechanistic, anatomic, or cognitive profiles. As symptoms may be the result of
underlying pathology and various pathologies may manifest similar symptoms, exclusive use of
symptoms as diagnostic criteria may limit progress towards targeted BD treatments that are
tailored to the individual (Insel and Cuthbert 2015; Drysdale et al. 2017). Non-diagnostically
biased clustering of patients using empirical data and machine learning algorithms has been
proposed as an approach to find specific biotypes that are more clinically informative than DSM
labels (Cho et al. 2019). Groundbreaking studies have found biotypes GM biotypes in adult BD,
schizophrenia, and major depressive disorder that corresponded to cognitive deficits, treatment
response, and clinical outcomes (Clementz et al. 2016; Drysdale et al. 2017). While pediatric
biotyping studies are relatively scant, promising findings have been found using
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neuropsychological data in ADHD and GM cortical thickness measures in pediatric BD (Zhang
et al. 2018; Fair et al. 2012). It is still unclear, however, whether GM volumes can separate
pediatric BD subjects into biotypes, and if so, how stable biotypes are over time.
The following chapter aims to be the first to investigate whether there are distinct
pediatric BD biotypes, i.e. clusters, using volumes from 101 GM areas and how these clusters
differ along cognitive, neuroanatomical, and clinical domains. In addition, a preliminary
longitudinal sample was acquired, and clusters were tested for longitudinal stability. It was
predicted that while the data-driven clusters would be associated with other empirical measures
of BD severity and neurocognitive impairment, the DSM subtypes would not. This hypothesized
outcome would therefore provide further evidence for transitioning to more quantitatively
informed diagnostic criteria.

Methods
A 2-component PCA was conducted on the ICV and scaled GM volumes of BDs.
Visualization of the PCA results indicated that there were likely 2 distinct clusters within the
BD sample (Figure 22). Using Sci-kitlearn’s k-means function, a 2-cluster k-means analysis was
run and empirically validated using silhouette scores. T-tests and Chi-square tests were used to
test for differences between clusters in age, gender, Young Mania Rating Scale scores (YMRS),
medication status, Hollingshead Socioeconomic scores, and DSM subtype. DSM subtypes were
also evaluated for differences in the above demographic and clinic measures using Chi-squares
and GLMS.
The GM mean diffusivity (MD) of regions that played the largest roles in BD clustering
were tested for group differences in a region of interest (ROI) analysis. This was done by using
FSL’s toolkit to create binary masks of each ROI and linearly registering the mask with the
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FLIRT function to the MD maps created in Chapter 2. All registrations were checked via visual
QC. The average MD value of each ROI was calculated compared across groups using GLMs.
Two sets of GLMs were conducted: one comparing just the two clusters and one that added HCs
as a comparison group. Both sets of GLM analyses controlled for age and gender and were FDR
corrected for multiple comparisons.
Using the CANTAB battery described in Chapter 3, differences in neurocognition were
evaluated for both BD clusters and BD DSM subtypes using GLMs that controlled for age and
gender. Results were FDR corrected for multiple comparisons.
The SVM from Chapter Four’s classification performance was re-evaluated using
clusters in order to determine whether the model performed better for one cluster compared to
another. Using the same methodology described in Chapter 4, a three-class SVM was used to
classify subjects as belonging to Cluster 1, Cluster 2, or the HC group.
Seven of the BD subjects, three from Cluster 1 and four from Cluster 2, were brought
back for a one-year follow-up. Follow-up T1 scans were acquired and processed using the same
protocol detailed in Chapter 2. The baseline ICV-corrected GM volumes of BD subjects were fit
using Sci-kit Learn’s StandardScaler, 2-Component PCA, and 2 cluster K-means algorithms.
The three fitted functions were then applied to the ICV-corrected GM volumes of the follow-up
scans in order to predict cluster classification.
The clustering pipeline was performed in Python 3.7 while the t-test, chi-square, and
GLM comparisons were performed in RStudio. The significance threshold for all t-tests, Chisquares, and GLMs was set at p<0.05.
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Results

The first two principal components accounted for 60% of the variance in the data and
separated the BD subjects into two clusters: 16 subjects in Cluster 1 and 27 in Cluster 2. The
average silhouette score of the two clusters was 0.56 (Figure 22). Looking at the individual
components, principal component 1 (PC 1) was a summary measure of small GM volumes, both
cortical and subcortical. PC 2, on the other hand, was an indicator of small CSF system size
(Figure 24, A and B). Thus, Cluster 2 was shown to have smaller brains than Cluster 1 and a
smaller CSF system (Figure 24, C and D).
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The principal components were fit to HC and the component values were compared
between the three groups (Figure 25). For principal component 1, there was a significant effect
of group [F(2, 88)=38.46, p= 9.93 X10-13], with Cluster 1 having smaller values, and thus larger
brain areas, than HCs and Cluster 2s (p= 2.07 X 10 -9, p= 7.19 X10-12). HCs also had smaller
principal component 1 values than Cluster 2 (p= 4.69 X10-3). Principal component 2, the CSF
system measures, had a significant effect of group [F(2,88)=6.15, p= 3.17 X10-3] and a
significant age X group interaction [F(1,88)=18.52, p= 4.33 X10-5]. Post-hoc analyses
confirmed that Cluster 2 has slower rate of CSF system growth than Cluster 1 and HCs (p=0.02;
p=0.03). CSF system growth trended faster in Cluster 1 than HCs as well (p=0.06),
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Characterizing Clusters
Cluster 1 and Cluster 2 did
not have significant differences in
medication status, Hollingshead
Socioeconomic scores, or DSM
subtypes (Table 6). While age and
gender differences between the
two groups did not reach
significance, they did trend, with
Cluster 1 having a larger proportion of females than males (X2=3.3, p=0.07, Table 5) and older
subjects (Cluster 1: M=14.27 ± 2.93 years, Cluster 2: M=12.43 ± 3.70, p=0.08, (Figure 26).
Cluster 1 had higher CDRS scores, but there were no significant differences in YMRS scores
(Figure 27). DSM subtypes were not significantly different in any clinical measure tested.
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Diffusivity Differences Between GM areas of Clusters
Principal component one, the summary
“small brain” measure was the main separator
of the BD clusters. In order to constrain the
diffusivity analysis to the most significant
ROIs, the distribution of the loadings in
principal component one was plotted, and any
area with loadings larger than the peak were
included in the analysis (Figure 28). Of the 38
brain regions that were
then included in the
analysis, only the
bilateral amygdala was
found to have higher
MD in Cluster 1 than
Cluster 2 (Right:
t=2.30, p=0.03; Left:
t=2.37, p=0.02). This
did not survive FDR correction. When HCs were included in the GLM group comparisons,
Cluster 1 was also shown to have higher mean diffusivity than HCs (Right: t=3.91, p=0.0002;
Left: t=3.02, p=0.003) (Figure 29). There were no differences between HCs and subjects in
Cluster 2 and there was no significant interaction between age and group.
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Cognitive Differences Between Clusters
GLMs comparing the cognitive performance of the two clusters found Cluster 2 subjects
took more moves on average than Cluster 1 to complete the 3-move SOC tasks (p=0.04) and
made more errors of omission in the AGN positive non-shift trials (p=0.05) (Figure 30). These
results did not
survive FDR
correction. When
HCs were included
as a comparison
group in the GLMs,
ten CANTAB
measures were significantly different between groups. Two measures, errors of omission on
AGN negative shift trials and CGT deliberation time, survived FDR correction. Results are
summarized in Figure 31. There were no cognitive differences between DSM subtypes.
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SVM Classification Performance Differences Between BD Clusters
As shown in Chapter 4, the SVM accuracy for the whole sample was 63%, with 84.2%
accuracy for HCs and 34.8% for BDs. Evaluating performance by cluster, however, revealed
that the SVM performs better for Cluster 1 than Cluster 2 (62.5% accuracy VS. 18.5%) (Figure
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32 B). A three-class SVM was run to classify subjects as members of Cluster 1, Cluster 2, or HC
groups (Figure 32 C). The model had an accuracy score of 57%, and the accuracy scores for
each subject group were as follows: Cluster 1- 68.8%, Cluster 2- 40.7%, HC- 61.4%.

Longitudinal Stability of BD Clusters
Five of the seven BD subjects who were rescanned
a year later remained in the same cluster (Figure 33). Two
subjects, one from Cluster 1 and one from Cluster 2, were
classified in a different cluster.

Discussion
Using whole brain GM parcellations and PCA +
K-means clustering, two anatomically distinct BD clusters
were identified which had unique depressive, cognitive,
and MD characteristics. As predicted, DSM subtypes did
not map on to the data-driven clusters and did not have any significant clinical, cognitive, or
anatomical associations. In addition, preliminary longitudinal data suggest substantial cluster
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stability. These results shed light on the heterogeneity within pediatric BD and highlight the
potential pitfalls of relying on DSM labels and assuming group homogeneity.
Cluster 1 was significantly more depressed than Cluster 2 and trended older and more
female. BD females tend to score higher than males on depression severity measures and report
more comorbidities (F. Benazzi 1999; Saunders et al. 2012; Parker et al. 2014). Older BD youth
have also been reported to be more depressed than their younger counterparts (Duax and
Youngstrom 2007). Thus, it is important to parse whether the depressive profile of Cluster 1 is a
result of subject demographics. Indeed, the GLM that assessed depression severity of the
clusters controlled for age and gender and yielded a significant difference. For additional
assurance, however, a linear model tested the relationship between age and CDRS scores and a
t-test looked for CDRS score differences between genders. Both tests were null. Therefore, the
link between the GM profile of Cluster 1 and depression severity is not predicated on
demographics but may be a product of GM abnormality.
GM microstructure was explored in an ROI analysis using MD maps. The bilateral
amygdala was found to have lower MD values in Cluster 1 than in Cluster 2 and the HC group.
Lower MD values indicate less movement of water, which in GM areas is often interpreted as a
sign of greater neuronal and glial density (Pierpaoli et al. 1996; Juranek et al. 2012). The clinical
impact of decreased MD in Cluster 1 is difficult to deduce as few studies have been published
on amygdalar MD and none of which examined a BD sample (Juranek et al. 2012; Neuner et al.
2011). However, Cluster 1 also had larger ICV-scaled amygdalar volumes. Interestingly, this
trait is reported in pediatric autism research while smaller amygdalar volume is characteristic of
both major depressive disorder and BD (Usher et al. 2010; Kempton 2011; Pfiefer et al. 2008;
C. M. Schumann 2004; Cynthia Mills Schumann et al. 2009). Greater amygdalar volume in
autism has also been correlated with increased feelings of depression and anxiety (Juranek et al.
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2006). Therefore, it is possible that the higher depression score in Cluster 1 may be linked to
higher amygdala volumes and MD. Further study of the role amygdalar microstructure may play
in mental disorders is necessary to substantiate this finding.
The neurocognitive data provided evidence for distinct deficits for each BD cluster.
Two-group comparisons highlighted differences in AGN and SOC performance, which test
affective information processing and spatial planning and problem solving, respectively. Cluster
2 performed worse in both measures, failing to identify words, such as “joy” or “happiness,” as
positive in the AGN task and taking more moves on average to solve certain SOC problems.
When the HC group was added as a comparison group, nine cognitive measures were found to
be significantly different between the three groups. Post-hoc pairwise comparisons indicated
that while Cluster 1 and Cluster 2 both had significantly lower RVP accuracies than HCs,
implying deficits in attention, the BD clusters exhibited differing patterns in all other significant
cognitive measures. The AGN task, for example, was the most noteworthy of all the CANTAB
assessments, making up five out of the nine significant measures. It was observed that Cluster 1
subjects made significantly more AGN errors of commission than HCs, indicating impaired
response control, while Cluster 2 made significantly more errors of omission, thus failing to
respond to the target stimulus (Seymour et al. 2015; McCormack et al. 2016). Therefore, while
both clusters showed deficits in affective processing compared to HCs, a commonly reported
characteristic of BD (McCormack et al. 2016), their specific impairments were in fact different.
Overall, Cluster 1 and Cluster 2 appear to differ in affective processing, attention, spatial
reasoning, and decision making. While in some of these domains, the difference between
clusters did not reach significance and/or did not survive FDR correction, one must
acknowledge the limited power provided by only having 16 subjects in Cluster 1. Nevertheless,
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the HC VS Cluster contrasts provide compelling evidence of consistently unique cluster deficits
that can guide future studies.
Re-examining the SVM BD vs HC classifications performed in Chapter 4 with clusters
revealed the crucial role heterogeneity of BD played in model performance. In the original
classifier, only 34.8% of BDs were classified correctly. However, when accuracy was broken
down by cluster, the model had a much higher classification accuracy for Cluster 1 than Cluster
2. It is clear that due to Cluster 1 having a very distinct GM profile, it had an outsized influence
on the hyperplane separating BDs from HCs. In addition, although Cluster 2 did have
significantly smaller grey matter areas than HC group, evaluation of the principal component
scores indicated that the differences between Cluster 1 and Cluster 2 were in fact much larger
than Cluster 2 and HCs. Therefore, Cluster 2 subjects were often mislabeled as HCs. The threeclass SVM, however, had a less skewed distribution of accuracy scores across Cluster 1, Cluster
2, and HCs. The overall model accuracy of the three-class SVM was 57% while the original
two-class SVM was 63%. While this may not appear at first glance to be an improvement in
classification, one must note that chance accuracy for a three-class SVM is 33.3% and 50% for a
two-class SVM. Therefore, to quantify how much better model performance was from chance,
the following formula was applied:

𝑀𝑜𝑑𝑒𝑙 𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 − 𝐶ℎ𝑎𝑛𝑐𝑒 𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦
𝐶ℎ𝑎𝑛𝑐𝑒 𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦

𝑋 100. The three-class SVM

performed 71.8% better than chance while the two class SVM was only 26.0% better. Despite
this improvement, however, the three-class model has too low of an accuracy score to be useful
in a clinical setting. Nevertheless, this experiment provides evidence for the importance of
accounting for heterogeneity in classification models. Should future studies employ similar
methodologies but with larger samples and training datasets, it is likely that model prediction
accuracy will improve. This will then increase the potential for the development of decision
support tools using GM volume parcellations.
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Our preliminary longitudinal data contained scans from seven subjects. While five
subjects remained in the same cluster a year later, more longitudinal data is needed for clearer
estimations of cluster stability. Furthermore, following subjects over the course of their
development will provide vital information as to whether the clusters differ in their prognosis,
e.g. suicidality, treatment resistance, hospitalizations, number of manic/depressive/hypomanic
episodes, etc. Future studies should also attempt to replicate using pediatric BD data from other
sites in order to better determine whether the clusters that emerged within this analysis may
have been a result of sampling and/or recruitment or whether the clusters have the potential to
be found in the general population.
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Chapter 7: Cortical Thickness and Gyrification of BD Clusters
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Introduction
The main volumetric signature of Cluster 1 was larger ICV-scaled GM volumes. An
exploration of the GM characteristics led to the discovery that the subjects from Cluster 1 had
significantly smaller ICVs than Cluster 2s and HCs. Interestingly, while Cluster 1’s average
total GM volume was
also less than the other
two groups, the
difference was not as
large (Figure 34, Table
7). Thus, dividing
Cluster 1’s GM volumes by
their relatively small ICVs, led
to large ICV scaled areas. The
question then arose as to how
Cluster 1 brains can accommodate proportionally larger GM regions. The two hypotheses that
were the most anatomically compelling were that 1) Cluster 1 brains had greater cortical
folding, i.e. gyrification, than Cluster 2 and HCs, and 2) Cluster 1 brains had greater cortical
thickness than Cluster 2 and HCs, which would allow cortical GM regions to occupy a larger
space.
Gyrification and cortical thickness follow similar patterns throughout development and
have both been shown to decrease over a person’s lifespan, with childhood and adolescence
experiencing the most rapid declines (Cao et al. 2017; Giedd and Rapoport 2010). Decreased
cortical thickness has been consistently reported in adult and pediatric BD (Janssen et al. 2014;
Rimol et al. 2010, 2012). Research on gyrification in BD, however, is more mixed. While the
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majority of gyrification studies report BD subjects to have altered gyrification trajectories with
less gyrification in adulthood than HCs (Cao et al. 2017; Palaniyappan and Liddle 2014; Nanda
et al. 2014), one study found no differences between BD and HC gyrification (Mirakhur et al.
2009), and one has reported increased gyrification in BD (Nenadic et al. 2015). Heterogeneity in
the BD population may account for the contradictory results reported in the literature.
The following chapter will test whether cortical morphology of the BD clusters is one of
the driving factors behind their GM differences. Provided Cluster 1 subjects exhibit thicker
cortices and/or greater gyrification, this analysis will further substantiate the proposition that the
two BD clusters should be viewed and analyzed as separate patient groups.

Methods
Cortical thickness and gyrification measures were obtained using FreeSurfer’s recon-all
processing pipeline (B. Fischl and Dale 2000; Schaer et al. 2012). Cortical thickness is
measured in mm while gyrification is measured using the local gyrification index (LGI), where
higher LGI values indicate greater cortical folding. Average cortical thickness and gyrification
were calculated across the whole cortex. GLMs were used to test for differences between
Cluster 1, Cluster 2, and HC groups for both measures and accounted for any group X age
interactions. Post-hoc was conducted using pairwise t-tests that were Bonferroni corrected for
multiple group comparisons.
In order to identify specific regions that may differ in cortical morphology, vertex-wise
comparisons of cortical thickness and gyrification were done using Qdec (Query, Design,
Estimate, Contrast) from FreeSurfer. Qdec is a single-binary application that uses whole brain
GLMs to perform two-group comparisons on surface data generated from the FreeSurfer
pipeline and is the recommended software for analyzing FreeSurfer generated gyrification
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measures (https://surfer.nmr.mgh.harvard.edu/fswiki/Qdec). Analyses of cortical thickness and
gyrification were done with 20 FWHM smoothing. All other parameters remained at default and
significance was set p<0.05. Preliminary analysis indicated significant relationships between
age and both cortical thickness and gyrification. Gender, however, did not have significant
differences for either cortical measure. Therefore, Qdec analyses only controlled for age. Qdec
output consists of an average subject map with colored voxels indicating where groups are
significantly different.
Regions that were within areas highlighted as significant in the Cluster 1 VS Cluster 2
output maps were included in a follow-up analysis intended to characterize cortical morphology
trajectories. GLMs were used to test for interactions between group and age. Post-hoc pairwise
t-tests with age interactions were also conducted. Significance for all analyses was set at p<0.05.

Results

Average cortical thickness was not significantly different between groups. There were
significant differences in average gyrification between groups [F(2,83)=7.14, p=1.4X10-3].
Cluster 1 was found to have less gyrification than HCs (p=0.003). There were no differences
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between Cluster 2 and the other two groups. There was, however, a significant interaction
between age and group, with gyrification decreasing with age in the Cluster 1 and HC groups,
while gyrification slightly increased with age for Cluster 2 [F(2,83)=5.14, p=7.8X10-3] (Figure
36 A). This observed increase in Cluster 2 was largely dependent on three subjects with low
gyrification indices. When the analysis was repeated without these outliers, the interaction only
trended towards significance [F(2,80)=2.3, p=0.10] (Figure 36 B). In addition, average
gyrification differences between Cluster 1 and Cluster 2 reached significance, with Cluster 1
having less gyrification.

Qdec surface analysis is shown in Figure 37. Qdec analysis of gyrification data showed
Cluster 1 and HCs to have minimal differences. Cluster 2, however, had significantly less
gyrification than Cluster 1, predominantly in the frontal and occipital cortices. Once the three
Cluster 2 outliers identified using average gyrification across the whole brain were removed,
however, significant areas were predominantly in the frontal cortex (Figure 38). Cluster 2 also
had less gyrification than HCs in much of the frontal, parietal, and temporal cortices. Regarding
cortical thickness, Cluster 1 subjects had greater cortical thickness than HCs and Cluster 2s in
areas within the parietal and temporal cortices. While Cluster 2 subjects also had thinner
61

cortices than HCs throughout the temporal and parietal cortices, they also had thicker cortices
than HCs in areas within the prefrontal cortex and the occipital lobe.
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For both gyrification and cortical thickness measures, the observed group differences
were largely driven by group X age interactions.
Table 8 contains the results of interactions between group X age for areas that were
highlighted in the Qdec Cluster 1 VS Cluster 2 gyrification analysis. Of the 12 regions tested, all
but four had a significant interaction between age and group (Figure 39). Three, however,
trended towards significance. In all eight areas with significant interactions, HCs had a more
rapid, i.e. steeper, decline in gyrification than Cluster 2. Cluster 1 had a steeper decline in four
areas and trended steeper in three. HCs and Cluster 1s trajectories did not differ in any region. In
the left precentral cortex, however, Cluster 1 trended steeper than HCs (p=0.09).
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Five of the 8 cortical regions identified by the Qdec Cluster 1 VS Cluster 2 cortical
thickness analysis had significant interactions between age and group (Table 9). In four of the
five areas with significant interactions, Cluster 1 had a steeper decline in thickness than Cluster
2 (Figure 40). Cluster 1 trended steeper than Cluster 2 in the right posterior cingulate. Cluster 1
had a steeper decline in thickness than HCs in the left paracentral area and the right posterior
cingulate. HCs had a significantly steeper decline than Cluster 2 in the bilateral superior
temporal and left paracentral areas. The left inferior parietal area trended steeper in HCs
compared to Cluster 2.
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Discussion

When examining differences between Cluster 1, Cluster 2, and HCs, the averaging of
gyrification and cortical thickness measures across the whole cortex resulted in markedly
different results than the Qdec vertex-wise analysis. Average gyrification was lower in Cluster 1
compared to the other two groups. When gyrification was examined in Qdec, however, Cluster 1
subjects had more gyrification than Cluster 2 in the frontal cortex and gyrification differences
between Cluster 1 and HCs were minimal. There were no significant differences in average
thickness between groups, yet Qdec analysis identified parietal and temporal regions where
Cluster 1 had thicker cortices than both Cluster 2s and HCs. Post-hoc testing and visualization
of significant areas highlighted in the Qdec Cluster 1 VS Cluster 2 analysis attributed the
patterns observed to be largely due to differences in age trajectories for gyrification and cortical
thickness between clusters. These results underscore how data averaged across the whole brain
may efface patterns in specific regions and thus not be representative of the complete picture
(Raznahan et al. 2010). The regional results, however, highlighted specific neurodevelopmental
abnormalities in both BD clusters.
Visualization of areas with significant cortical thickness and gyrification differences
between clusters suggests that Cluster 2 subjects experience slowed cortical development
compared to Cluster 1 and HCs. Healthy trajectories show prominent decreases in both
gyrification and thickness during childhood and adolescence, which was exhibited by the HC
and Cluster 1 groups (Piccolo et al. 2016). This may impact Cluster 2 subjects’ cognitive
development as slower rates of cortical thinning have been linked to increased hyperactivity and
impulsivity (Giedd and Rapoport 2010).
In significant regions identified by the Qdec analyses, Cluster 1 neurodevelopment
followed a distinctive pattern: Younger subjects had high levels of gyrification and thick
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cortices, which was then followed by marked decreases in both morphological measures
throughout adolescence. This trajectory is also exhibited in HCs. However, in the right
posterior cingulate and left paracentral areas Cluster 1 exhibited more rapid cortical thinning
than HCs, and in the left precentral cortex, decreases in gyrification trended faster in Cluster 1
than HCs. Interestingly, this pattern of accelerated thinning and de-gyrification during
adolescence has been reported in autistic spectrum disorder (Zielinski et al. 2014). Thus, the
cortical development of Cluster 1 may point to disruptions in the typical synaptic pruning
process.
A 2018 study by Zhang et al examining cortical thickness in pediatric BD found two
biotypes similar to the clusters reported in this study: Compared to HCs, biotype 1, which
contained 16 out of the 52 subjects, had thicker cortices in the temporal and parietal lobes while
biotype 2 had thinner cortices in the same cortical areas (Zhang et al. 2018). Beyond their
cortical thickness differences, the two biotypes also responded differentially to quetiapine, an
atypical antipsychotic. There is notable consonance between the Zhang et al study and the
results presented in this dissertation, specifically in the cortical thickness differences that
characterize the biotypes as well as the biotype to BD sample ratios. This, in turn, provides
preliminary evidence for the reproducibility of the clusters and suggests that these clusters may
have therapeutic relevance. Indeed, two studies are not sufficient for complete validation of the
clusters as unique BD biotypes and more corroborating research is needed. Nevertheless, the
identification of these two pediatric BD clusters that exhibit unique GM morphology and
neurocognitive deficits is a major step forward in the quest to understand and ultimately treat
BD heterogeneity.
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Chapter 8: Discussion
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The present dissertation provided an exploration of two potential approaches for the
development of biologically informed decision support tools for the characterization of pediatric
BD. While the normative development model was unable to quantify BD risk at an individual
level, it nevertheless emphasized the heterogeneous nature of both healthy and BD
development. The clustering analysis, however, was successful at parsing the variance in the BD
sample which resulted in the identification of two distinct BD biotypes. Whereas the BD
clusters mapped onto specific anatomical and neurocognitive patterns, symptom-based DSM
subtypes were not associated with any empirical measures of mental health. Hence, these
findings are testament to the potential of unsupervised and unbiased computational methods in
the future of BD diagnostics.
The results of the classical statistical analysis from Chapter 3 and the SVM classification
in Chapter 4 serve as an example of how assumptions of BD homogeneity can fail to identify
meaningful patterns in the data. Using standard methods of diagnosis, ICV correction, and tests
for group differences, the results were largely in accordance with the BD literature and would
have further entrenched expectations of a specific BD profile. As was shown in the clustering
analysis from Chapter 6, this approach effectively overlooked Cluster 1, which had a unique
biotype with stark anatomical differences and accounted for over a third of our BD sample.
Indeed, Cluster 1 subjects received the same diagnosis and were medicated similarly to Cluster
2. This highlights how symptom-based diagnostics often fail to reflect neurobiological
mechanisms. It is highly likely that distinct biological abnormalities may require different
methods of treatment (Yun and Lee 2019). Therefore, Cluster 1 subjects may not respond to
therapies that are developed and tested within the typical symptomologic framework. Thus, in
order to transition psychiatry into the field of precision medicine, research must refrain from
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making assumptions of homogeneity, otherwise specific biotypes will be overlooked and
averaged out (Wolfers et al. 2018).
In the examinations of the anatomical and neurocognitive differences between the BD
clusters, Cluster 2 most frequently adhered to the patterns reported in the BD literature. The
Cluster 2 profile included smaller GM areas, impaired executive planning, attention, and spatial
reasoning, and abnormal cortical thickness and gyrification trajectories. As Cluster 2 accounted
for the majority of BD subjects within the sample, with 27 of the 43 subjects, it is likely that
Cluster 2 contains subjects who mostly match the common clinical characterization of BD.
Cluster 1, on the other hand, had unique abnormalities that did not fit the typical BD
neuroanatomical profile. Rather, some of the identified Cluster 1 patterns, such as enlarged
amygdalae and accelerated cortical thinning in adolescence, have been reported in autistic
spectrum disorder (ASD) (Kohli et al. 2019; Ulay and Ertuğrul 2009). While none of the BD
subjects had comorbid ASD diagnoses, it is important to note the high rates of BD/ASD
comorbidity and the possible etiological parallels between the two disorders (Munesue et al.
2008; Kerbeshian and Burd 1996).
Future studies should address not only the heterogeneity that exists within disorders but
also the blurred boundaries between them. Many symptomological criteria are shared among
mental disorders, which increases subjectivity in current clinical practices. Consequently, sole
reliance on observation makes psychiatry susceptible to increased diagnostic errors and
decreased rates of treatment response (Saeed 2018; Gillan et al. 2017). Studies have shown
clinical overlap and/or high rates of comorbidity between BD and major depressive disorder,
ADHD, schizophrenia, and ASD (Franco Benazzi 2003), and the similarities between BD
Cluster 1 subjects and youth with ASD are a testament to this fact. Psychiatric diagnosis must
evolve to center around the distinct deficits exhibited rather than non-mechanistically specific
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labels in order to increase therapeutic efficacy. Thus, future studies may build upon these
findings to develop targeted treatments based on a pediatric patient’s GM biotype, making
personalized care accessible during a critical period of mental development.
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